A carregar...
The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
Following the most recent modification by the American Academy of Pediatrics, based on American studies on RSV epidemiology, the Italian Drug Agency (AIFA) decided to limit the total financial coverage of the palivizumab prescription by the National Health Service only to the < 29 wGA group and a...
Na minha lista:
| Publicado no: | Ital J Pediatr |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557508/ https://ncbi.nlm.nih.gov/pubmed/28807039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-017-0390-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|